Poxel S.A. (EPA:POXEL)
France · Delayed Price · Currency is EUR 0.2810
-0.0380 (-11.91%)
Apr 2, 2026, 5:38 PM CET
Poxel Market Cap
Poxel has a market cap or net worth of €15.1 million as of April 2, 2026. Its market cap has increased by 37.22% in one year.
Market Cap
15.10M
Enterprise Value
75.05M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.28
Market Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 193.09M to 15.10M, a decrease of -92.18%. That is a compound annual growth rate of -20.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 15.10M | 20.09% |
| Dec 31, 2025 | 12.57M | 69.26% |
| Dec 31, 2024 | 7.43M | -61.80% |
| Dec 29, 2023 | 19.45M | -28.41% |
| Dec 30, 2022 | 27.16M | -80.72% |
| Dec 31, 2021 | 140.90M | -22.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 42.08M |
| Nicox | 36.13M |
| genOway Société anonyme | 23.23M |
| Advicenne | 21.08M |
| GenSight Biologics | 20.34M |
| Aelis Farma | 17.67M |
| NFL Biosciences | 13.66M |
| Oncodesign Precision Medicine Société anonyme | 8.61M |